Furthermore, even though the general progression of amyloid followed by tau is similar for people with DS and people with ADAD, there are observable yet subtle differences in the spatial distribution, timing, and magnitude of tau PET burden between these two groups. The gene discussed is MAPT; the disease is Dravet syndrome.